Mahmood Siddique, DO
Internal Medicine · Lawrenceville, NJNPI 1700976073
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $97,144 of the $109,590 with a category attached, or 88.6%. AbbVie accounts for 82.7% of it on its own, with 36 other manufacturers making up the rest. Among internal medicine clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 552 payments — averaging $198.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$91K
- Axsome Therapeutics, Inc.$14K
- AstraZeneca$1K
- Novo Nordisk$650
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$398
- Harmony Biosciences LLC$386
- plus $2K from 31 others
Across 25 payments — averaging $5503.19 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$128K
- AstraZeneca$7K
- Zevra Therapeutics Inc$3K
What the payments were for
- Speaking & faculty fees$97,14489%
- Travel & lodging$3,1393%
- Food & beverage$8,9928%
- Education$3150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 299 | $90,650 |
| Axsome Therapeutics, Inc. | 44 | $14,239 |
| AstraZeneca | 40 | $1,441 |
| Novo Nordisk | 37 | $650 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 27 | $398 |
| Harmony Biosciences LLC | 12 | $386 |
| Jazz Pharmaceuticals Inc. | 10 | $272 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $263 |
| Lilly USA, LLC | 17 | $251 |
| Ironshore Pharmaceuticals Inc. | 4 | $163 |
| Johnson & Johnson(2 entities) | 6 | $111 |
| Merck | 6 | $83 |
| Lundbeck LLC | 5 | $80 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $70 |
| Avadel CNS Pharmaceuticals, LLC | 4 | $65 |
| Amgen(2 entities) | 4 | $57 |
| Vivus LLC | 3 | $43 |
| Sanofi-aventis U.S. LLC | 3 | $41 |
| Bayer | 2 | $30 |
| Eisai Inc. | 2 | $26 |
| Indivior Inc. | 2 | $26 |
| Merz North America, Inc. | 1 | $19 |
| Supernus Pharmaceuticals, Inc. | 1 | $18 |
| Itamar Medical Inc | 1 | $17 |
| Exact Sciences | 1 | $16 |
| Dexcom, Inc. | 1 | $16 |
| Sanofi | 1 | $16 |
| Therapeuticsmd, Inc. | 1 | $16 |
| Philips North America LLC | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Mallinckrodt Enterprises LLC | 1 | $15 |
| GSK | 1 | $14 |
| Pfizer | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$109,590 in reported general payments places this provider in the 95th percentile of 4,032 internal medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 270 | $330,082 |
| OzempicSemaglutide | 84 | $122,627 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 37 | $42,203 |
| EliquisApixaban | 36 | $40,410 |
| FarxigaDapagliflozin Propanediol | 25 | $30,680 |
| TrulicityDulaglutide | 15 | $25,190 |
| Breo ElliptaFluticasone/Vilanterol | 34 | $25,035 |
| VraylarCariprazine Hcl | 15 | $22,527 |
| Spiriva RespimatTiotropium Bromide | 28 | $22,033 |
| JanumetSitagliptin Phos/Metformin Hcl | 16 | $15,769 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 13 | $13,267 |
| LinzessLinaclotide | 11 | $8,385 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 14 | $8,281 |
| TirosintLevothyroxine Sodium | 21 | $7,903 |
| EdarbyclorAzilsartan Med/Chlorthalidone | 14 | $7,167 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $251 | $355,272285 claims |
| Novo NordiskOzempic | $650 | $122,62784 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta | $14 | $72,54786 claims |
| PfizerEliquis | $14 | $40,41036 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $1,441 | $38,96139 claims |
| AbbVieVraylar, Linzess, Synthroid | $90,650 | $34,20654 claims |
| MerckJanumet, Janumet Xr | $83 | $29,03629 claims |
| Arbor Pharmaceuticals, Inc.Edarbyclor | $15 | $7,16714 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,032 internal medicine providers in New Jersey.
Other internal medicine in Lawrenceville
- David ShulkinMorristown$1.7M
- Howard UdermanLakewood$955K
- Darshi SunderamEast Orange$530K
- Annika DrongeEmerson$401K
- Stephen MarcellaNew Brunswick$331K
- Viju VijaysadanKinnelon$325K
- Mark MonaneWoodcliff Lake$268K
- Martin BedigianLivingston$240K
- Rameck HuntPlainsboro$217K
- Angel LazoSecaucus$195K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.